Skip to content

Evaluation of the Preventive Effects of Different Oral Iron Formulations on Iron Deficiency and Iron Deficiency Anemia in Pregnancy

Evaluation of the Preventive Effects of Different Oral Iron Formulations on Iron Deficiency and Iron Deficiency Anemia in Pregnancy

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600122683
Enrollment
Unknown
Registered
2026-04-16
Start date
2026-04-20
Completion date
Unknown
Last updated
2026-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

iron deficient anemia

Interventions

Group A:Iron Dextran 50 mg once daily
Group B:Iron Dextran 100 mg once daily

Sponsors

The First Affiliated Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Singleton pregnancy, gestational age 12-16 weeks (confirmed by ultrasound); 2. Hemoglobin (Hb) >=110 g/L, serum ferritin (SF) >=30 µg/L, non-anemic pregnant women without high risk of iron deficiency; 3. Age 18-40 years; 4. Signed informed consent form.

Exclusion criteria

Exclusion criteria: 1. Multiple pregnancies or conception through assisted reproductive technology; 2. Complicated by chronic diseases (such as kidney disease, autoimmune disease, malignant tumor); 3. History of iron allergy or treatment with iron preparations within the past month; 4. Active infection (C-reactive protein >=10 mg/L) or hematologic diseases.

Design outcomes

Primary

MeasureTime frame
Incidence of iron deficiency;Incidence of iron deficiency anemia;Subjective compliance: supplemented and verified by subjects’ self-reported medication diaries. ? ,? ?;

Secondary

MeasureTime frame
Objective Compliance Rate;Maternal and infant clinical outcome indicators (preterm birth rate; incidence of postpartum hemorrhage; incidence of low birth weight infants; adequacy rate of cord blood ferritin; cord blood hemoglobin levels);

Countries

China

Contacts

Public ContactZhang Xuemei

The First Affiliated Hospital of Chongqing Medical University

zhangxuemei409@163.com+86 138 8394 3508

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 23, 2026